
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
GlaxoSmithKline’s Catherine Sohn, senior vice president of worldwide business development and strategic alliances for consumer healthcare, talks about the strength her father gave her to pursue her dreams and why it makes her want to give back. PLUS: Sohn shares her excitement over GSK’s new US head of the pharma business, Deidre Connelly.






